Rapid Dose Therapeutics Corp. (DOSE.CN)
CAD 0.19
(5.56%)
CAD 0.19
(5.56%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.88 Million CAD | -16.09% |
| 2022 | 2.24 Million CAD | -26.77% |
| 2021 | 3.06 Million CAD | -19.93% |
| 2020 | 3.83 Million CAD | -10.68% |
| 2019 | 4.28 Million CAD | -25.82% |
| 2018 | 5.78 Million CAD | 33791.48% |
| 2017 | 17.06 Thousand CAD | 1789.7% |
| 2016 | 903.00 CAD | 0.0% |
| 2015 | - CAD | -100.0% |
| 2014 | 8687.00 CAD | 13473.44% |
| 2013 | 64.00 CAD | -99.81% |
| 2012 | 33.47 Thousand CAD | -84.92% |
| 2011 | 222.03 Thousand CAD | -10.59% |
| 2010 | 248.33 Thousand CAD | 51.52% |
| 2009 | 163.89 Thousand CAD | 8.09% |
| 2008 | 151.62 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.71 Million CAD | -5.4% |
| 2024 Q1 | 1.81 Million CAD | -3.73% |
| 2023 Q4 | 1.88 Million CAD | -5.45% |
| 2023 Q3 | 1.99 Million CAD | -4.91% |
| 2023 Q2 | 2.09 Million CAD | 1.11% |
| 2023 Q1 | 2.07 Million CAD | -7.69% |
| 2023 FY | 1.88 Million CAD | -16.09% |
| 2022 Q3 | 2.73 Million CAD | -2.48% |
| 2022 Q4 | 2.24 Million CAD | -17.88% |
| 2022 FY | 2.24 Million CAD | -26.77% |
| 2022 Q1 | 2.93 Million CAD | -4.39% |
| 2022 Q2 | 2.8 Million CAD | -4.37% |
| 2021 Q1 | 6.47 Million CAD | 69.09% |
| 2021 Q2 | 6.44 Million CAD | -0.47% |
| 2021 Q3 | 5.81 Million CAD | -9.77% |
| 2021 Q4 | 3.06 Million CAD | -47.27% |
| 2021 FY | 3.06 Million CAD | -19.93% |
| 2020 Q2 | 4.35 Million CAD | 4.63% |
| 2020 Q3 | 4.36 Million CAD | 0.04% |
| 2020 Q4 | 3.83 Million CAD | -12.13% |
| 2020 FY | 3.83 Million CAD | -10.68% |
| 2020 Q1 | 4.16 Million CAD | -2.88% |
| 2019 Q4 | 4.28 Million CAD | -10.4% |
| 2019 FY | 4.28 Million CAD | -25.82% |
| 2019 Q1 | 4.66 Million CAD | -19.29% |
| 2019 Q3 | 4.78 Million CAD | 12.62% |
| 2019 Q2 | 4.25 Million CAD | -8.93% |
| 2018 Q1 | 1.16 Million CAD | 60.47% |
| 2018 FY | 5.78 Million CAD | 33791.48% |
| 2018 Q4 | 5.78 Million CAD | -6.97% |
| 2018 Q3 | 6.21 Million CAD | -8.32% |
| 2018 Q2 | 6.78 Million CAD | 479.99% |
| 2017 FY | 17.06 Thousand CAD | 1789.7% |
| 2017 Q1 | 1429.00 CAD | -75.23% |
| 2017 Q2 | 17.06 Thousand CAD | 1094.12% |
| 2017 Q3 | 1374.00 CAD | -91.95% |
| 2017 Q4 | 728.53 Thousand CAD | 52922.56% |
| 2016 Q2 | 903.00 CAD | 0.0% |
| 2016 Q3 | 31.11 Thousand CAD | 3345.85% |
| 2016 Q4 | 5768.00 CAD | -81.46% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 FY | 903.00 CAD | 0.0% |
| 2015 Q2 | - CAD | -100.0% |
| 2015 FY | - CAD | -100.0% |
| 2015 Q3 | 732.00 CAD | 0.0% |
| 2015 Q4 | - CAD | -100.0% |
| 2015 Q1 | 12.85 Thousand CAD | 30.97% |
| 2014 Q3 | 6174.00 CAD | -28.93% |
| 2014 Q1 | - CAD | -100.0% |
| 2014 FY | 8687.00 CAD | 13473.44% |
| 2014 Q4 | 9817.00 CAD | 59.01% |
| 2014 Q2 | 8687.00 CAD | 0.0% |
| 2013 Q2 | 64.00 CAD | -98.9% |
| 2013 Q1 | 5836.00 CAD | -1.73% |
| 2013 FY | 64.00 CAD | -99.81% |
| 2013 Q4 | 23.8 Thousand CAD | 134.0% |
| 2013 Q3 | 10.17 Thousand CAD | 15796.88% |
| 2012 Q4 | 5939.00 CAD | -73.85% |
| 2012 Q1 | 140.15 Thousand CAD | -25.28% |
| 2012 Q2 | 33.47 Thousand CAD | -76.12% |
| 2012 Q3 | 22.71 Thousand CAD | -32.15% |
| 2012 FY | 33.47 Thousand CAD | -84.92% |
| 2011 Q1 | 205.63 Thousand CAD | -4.38% |
| 2011 Q3 | 198.47 Thousand CAD | -10.61% |
| 2011 Q4 | 187.57 Thousand CAD | -5.49% |
| 2011 FY | 222.03 Thousand CAD | -10.59% |
| 2011 Q2 | 222.03 Thousand CAD | 7.98% |
| 2010 Q3 | 244.22 Thousand CAD | -1.66% |
| 2010 FY | 248.33 Thousand CAD | 51.52% |
| 2010 Q2 | 248.33 Thousand CAD | -3.27% |
| 2010 Q1 | 256.73 Thousand CAD | -4.45% |
| 2010 Q4 | 215.04 Thousand CAD | -11.95% |
| 2009 Q3 | 141.34 Thousand CAD | -13.75% |
| 2009 Q4 | 268.69 Thousand CAD | 90.09% |
| 2009 FY | 163.89 Thousand CAD | 8.09% |
| 2009 Q2 | 163.89 Thousand CAD | 0.0% |
| 2008 FY | 151.62 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | 4.19 Million CAD | 55.048% |
| Asep Medical Holdings Inc | 25.61 Million CAD | 92.64% |
| BetterLife Pharma Inc. | 324.74 Thousand CAD | -480.504% |
| BioVaxys Technology Corp. | 113.47 Thousand CAD | -1561.259% |
| ChitogenX Inc. | 534 Thousand CAD | -253.027% |
| Defence Therapeutics Inc. | 477.74 Thousand CAD | -294.594% |
| Entheon Biomedical Corp. | 401.07 Thousand CAD | -370.025% |
| Gemina Laboratories Ltd. | 1.45 Million CAD | -29.45% |
| Glow Lifetech Corp. | 1.91 Million CAD | 1.456% |
| Lexston Life Sciences Corp. | 750.94 Thousand CAD | -151.037% |
| Pharmala Biotech Holdings Inc. | 2.41 Million CAD | 21.86% |
| Doseology Sciences Inc. | 1.1 Million CAD | -71.032% |
| MYND Life Sciences Inc. | 797.54 Thousand CAD | -136.371% |
| Nova Mentis Life Science Corp. | 31.05 Thousand CAD | -5969.619% |
| PharmaTher Holdings Ltd. | 2.58 Million CAD | 27.208% |
| PreveCeutical Medical Inc. | 181.51 Thousand CAD | -938.6% |
| Telescope Innovations Corp. | 3.02 Million CAD | 37.651% |